![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -0.16% | 12,106.00 | 12,120.00 | 12,122.00 | 12,190.00 | 12,024.00 | 12,080.00 | 999,558 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.55 | 187.98B |
RNS Number:5919K AstraZeneca PLC 30 April 2003 FOR IMMEDIATE RELEASE: ASTRAZENECA PLC ANNUAL GENERAL MEETING : 30 APRIL 2003 AstraZeneca PLC announced the results of the polls taken at its Annual General Meeting today in respect of Items 5(e), 9 and 10 on the Agenda, as follows: Item 5(e): Ordinary Resolution to re-elect Sir Peter Bonfield as a Director: VOTES FOR: 830,994,339 (95.57%) VOTES AGAINST: 38,475,456 (4.43%) This Resolution was passed as an Ordinary Resolution at the AGM. Percy Barnevik, Chairman of AstraZeneca PLC, said "My Board colleagues and I are delighted that Sir Peter Bonfield has been re-elected as a Director with such overwhelming support following the poll held at today's Annual General Meeting. Sir Peter is making a key contribution to AstraZeneca in his role both as the senior Non-Executive Director and also as Chairman of the Remuneration Committee." Item 9: Special Resolution to authorise the Directors to allot unissued shares: VOTES FOR: 813,215,344 (95.90%) VOTES AGAINST: 34,776,305 (4.10%) This Resolution was passed as a Special Resolution at the AGM. Item 10: Special Resolution to authorise the Company to purchase its own shares: VOTES FOR: 890,748,684 (99.86%) VOTES AGAINST: 1,261,770 (0.14%) This Resolution was passed as a Special Resolution at the AGM. Under the Company's Articles of Association, voting on all Special Resolutions is conducted by poll. G H R Musker Company Secretary 30 April 2003 This information is provided by RNS The company news service from the London Stock Exchange END RAGEAKLEDADDEFE
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions